Latest Ratios: P/E Ratio 22.1x · EV/EBITDA 14.7x · ROE 9.3%. (2007–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.1B | $2.0B | $2.2B | $1.5B | $1.6B | $1.5B | $1.9B | $1.4B | $891M | $405M | $404M |
| Enterprise Value | $2.3B | $2.1B | $2.4B | $1.6B | $1.7B | $1.6B | $2.0B | $1.4B | $838M | $394M | $421M |
| P/E Ratio → | 22.06 | 20.61 | 29.63 | 24.24 | 35.03 | 33.28 | 56.29 | 54.93 | 51.04 | 29.74 | 33.70 |
| P/S Ratio | 1.51 | 1.39 | 1.89 | 1.43 | 1.69 | 1.74 | 2.44 | 2.14 | 1.72 | 0.95 | 1.01 |
| P/B Ratio | 1.95 | 1.83 | 2.24 | 2.14 | 2.54 | 2.62 | 3.60 | 2.91 | 3.23 | 2.31 | 2.54 |
| P/FCF | 20.67 | 19.09 | 19.74 | 14.73 | 16.63 | 43.11 | 18.21 | 187.24 | 31.99 | 8.24 | — |
| P/OCF | 19.24 | 17.77 | 18.71 | 13.49 | 15.32 | 38.04 | 17.08 | 115.25 | 26.83 | 7.67 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.48 | 2.04 | 1.53 | 1.80 | 1.85 | 2.57 | 2.09 | 1.62 | 0.93 | 1.05 |
| EV / EBITDA | 14.66 | 13.60 | 20.24 | 15.46 | 20.63 | 19.85 | 34.71 | 29.89 | 26.63 | 12.34 | 19.03 |
| EV / EBIT | 16.39 | 15.38 | 21.97 | 17.58 | 24.72 | 24.12 | 43.49 | 37.35 | 32.96 | 14.78 | 23.07 |
| EV / FCF | — | 20.31 | 21.31 | 15.81 | 17.64 | 45.83 | 19.14 | 183.14 | 30.08 | 8.02 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.5% | 32.5% | 32.5% | 32.1% | 31.5% | 31.2% | 29.6% | 27.6% | 26.7% | 27.2% | 26.5% |
| Operating Margin | 9.7% | 9.7% | 8.9% | 8.6% | 7.2% | 7.6% | 5.8% | 5.4% | 4.4% | 5.9% | 3.9% |
| Net Profit Margin | 6.7% | 6.7% | 6.4% | 5.9% | 4.8% | 5.2% | 4.3% | 3.9% | 3.4% | 3.2% | 3.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.3% | 9.3% | 8.8% | 9.3% | 7.6% | 8.3% | 6.7% | 6.7% | 7.8% | 8.1% | 8.0% |
| ROA | 6.7% | 6.7% | 6.0% | 6.4% | 4.9% | 4.9% | 4.3% | 5.1% | 5.6% | 5.5% | 5.7% |
| ROIC | 8.8% | 8.8% | 7.9% | 8.8% | 7.4% | 7.7% | 6.3% | 7.8% | 8.9% | 11.1% | 7.3% |
| ROCE | 10.9% | 10.9% | 9.6% | 10.8% | 8.4% | 8.4% | 6.9% | 8.2% | 9.0% | 12.7% | 9.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.19 | 0.19 | 0.28 | 0.25 | 0.28 | 0.46 | 0.46 | 0.17 | 0.06 | 0.25 | 0.16 |
| Debt / EBITDA | 1.35 | 1.35 | 2.35 | 1.67 | 2.15 | 3.28 | 4.24 | 1.80 | 0.55 | 1.35 | 1.13 |
| Net Debt / Equity | — | 0.12 | 0.18 | 0.16 | 0.15 | 0.16 | 0.18 | -0.06 | -0.19 | -0.06 | 0.11 |
| Net Debt / EBITDA | 0.82 | 0.82 | 1.50 | 1.05 | 1.18 | 1.18 | 1.67 | -0.67 | -1.69 | -0.34 | 0.77 |
| Debt / FCF | — | 1.22 | 1.58 | 1.07 | 1.01 | 2.72 | 0.92 | -4.09 | -1.91 | -0.22 | — |
| Interest Coverage | 14.30 | 14.30 | 13.85 | 8.32 | 7.76 | 11.40 | 14.15 | 11.68 | 5.07 | 5.96 | 7.83 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Quick Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Cash Ratio | 0.55 | 0.55 | 0.63 | 0.45 | 0.61 | 1.44 | 1.01 | 1.28 | 1.14 | 1.03 | 0.16 |
| Asset Turnover | — | 0.99 | 0.82 | 1.03 | 1.01 | 0.91 | 0.86 | 1.02 | 1.46 | 1.59 | 1.73 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 41.74 | 42.76 | 40.02 | 48.42 | 61.67 | 64.20 | 86.21 | 70.85 | 80.19 | 107.26 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.5% | 4.9% | 3.4% | 4.1% | 2.9% | 3.0% | 1.8% | 1.8% | 2.0% | 3.4% | 3.0% |
| FCF Yield | 4.8% | 5.2% | 5.1% | 6.8% | 6.0% | 2.3% | 5.5% | 0.5% | 3.1% | 12.1% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $18M | $17M | $16M | $16M | $16M | $16M | $14M | $13M | $12M | $12M |
Includes 30+ ratios · 19 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ADUS stock.
Addus HomeCare Corporation's current P/E ratio is 22.1x. The historical average is 29.5x. This places it at the 27th percentile of its historical range.
Addus HomeCare Corporation's current EV/EBITDA is 14.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.6x.
Addus HomeCare Corporation's return on equity (ROE) is 9.3%. The historical average is 7.9%.
Based on historical data, Addus HomeCare Corporation is trading at a P/E of 22.1x. This is at the 27th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Addus HomeCare Corporation has 32.5% gross margin and 9.7% operating margin.
Addus HomeCare Corporation's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Labor cost inflation and regulatory mandates
Metrics are mathematically derived from official filings.
Margin Ceiling at 32%
Gross margin has hovered near 32% for ten quarters, with Q2 2026 at 32.2%, reflecting Medicaid reimbursement constraints on labor costs. According to recent SEC filings, operating margin improved to 10.3%.
The stability of gross margin around 32% suggests a structural ceiling imposed by state-set reimbursement rates, which limit the spread over caregiver wages. Operating margin's sequential improvement to 10.3% in Q2 2026 from 9.4% in Q1 2026 indicates early operating leverage, but the high single-digit range underscores the labor-intensive model. Net margin of 7.3% remains thin, leaving limited buffer for wage inflation or regulatory shocks like the proposed 80/20 mandate.
ROIC Stuck in Low Single Digits
ROIC has remained between 2.0% and 2.7% over the past ten quarters, with Q2 2026 at 2.5%. As reported in financial statements, this suggests the company is not compounding returns on its growing capital base.
Despite revenue growth and deleveraging, ROIC has not improved, indicating that acquisitions and organic investments are generating returns barely above the cost of capital. The asset base is dominated by goodwill ($1.0B, 67% of total assets), which inflates invested capital without contributing to operational efficiency. This may imply that the company's M&A strategy is value-accretive only if integration yields synergies, which is not yet evident in the return metrics.
Working Capital Efficiency Stable
DSO has remained steady between 33 and 39 days over ten quarters, with Q2 2026 at 36 days. Based on reported figures, the cash conversion cycle is not calculable due to unavailable inventory data, but DSO stability suggests consistent collections.
The stable DSO indicates that the company manages state payor collections effectively, despite historical Illinois payment delays. The absence of inventory data is consistent with a service business, but the lack of DPO data limits full working capital analysis. Asset turnover has been flat at 0.25-0.28, reflecting the low capital intensity of the model, but also suggesting that revenue growth is not translating into higher asset productivity.
Deleveraging Strengthens Balance Sheet
Debt-to-equity fell from 0.28 in 2024Q4 to 0.09 in 2026Q2, with interest coverage rising to 22.92. According to recent financial statements, the company has significantly reduced leverage post-Gentiva acquisition.
The rapid deleveraging, with total debt down to $108.8M from $273.1M, reduces refinancing risk and interest expense pressure. Interest coverage of 22.92 in Q2 2026 is robust, indicating that debt service is highly comfortable. However, the D/EBITDA ratio of 2.53 suggests that while leverage is manageable, it is not negligible, and future M&A could re-lever the balance sheet.
Liquidity Adequate but Cash Declining
Current ratio improved to 1.69 in Q2 2026 from 1.35 in 2024Q1, but cash fell to $99.6M from its 2024Q3 peak. As reported in financial statements, liquidity remains sufficient for short-term obligations.
The current ratio of 1.69 indicates that current assets cover current liabilities comfortably, with quick ratio equal to current ratio due to minimal inventory. However, the declining cash balance, coupled with ongoing acquisition outflows, suggests that liquidity could tighten if cash generation slows. The company's reliance on state payors introduces collection timing risk, which could strain liquidity during budget impasses.
Misapplied ROE in Service Model
ROE of 2.4% in Q2 2026 appears low, but this metric is misleading for a company with a goodwill-heavy balance sheet. Based on reported figures, ROIC is a better measure of operational performance.
ROE is depressed by the large equity base built from retained earnings and acquisition-related goodwill, which does not reflect the cash-generating ability of the core business. The company's true earning power is better captured by operating margin and cash flow metrics, such as FCF margin of 9.8%. Investors should focus on ROIC and cash conversion rather than ROE when evaluating this asset-light, acquisition-driven model.